Company page
Moonlake Immunotherapeutics
Moonlake Immunotherapeutics is a public company traded under the ticker MLTX in the American market. The company has a market capitalization of approximately $1.41 billion. Moonlake focuses on developing innovative immunotherapies to address unmet medical needs.
- Ticker
- MLTX
- Market cap
- $1.41B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major